Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge

Newcastle disease virus (NDV) and Salmonella Pullorum have significant damaging effects on the poultry industry, but no previous vaccine can protect poultry effectively. In this study, a recombinant-attenuated S. Pullorum strain secreting the NDV hemagglutinin-neuraminidase (HN) protein, C79-13Δ crp Δ asd (pYA-HN), was constructed by using the suicide plasmid pRE asd -mediated bacteria homologous recombination method to form a new bivalent vaccine candidate against Newcastle disease (ND) and S . Pullorum disease (PD). The effect of this vaccine candidate was compared with those of the NDV LaSota and C79-13Δ crp Δ asd (pYA) strains. The serum hemagglutination inhibition antibody titers, serum immunoglobulin G (IgG) antibodies, secretory IgA, and stimulation index in lymphocyte proliferation were increased significantly more ( p < 0.01) in chickens inoculated with C79-13Δ crp Δ asd (pYA-HN) than with C79-13Δ crp Δ asd (pYA) but were not significantly increased compared with the chickens immunized with the LaSota live vaccine ( p > 0.05). Moreover, the novel strain provides 60% and 80% protective efficacy against the NDV virulent strain F48E9 and the S . Pullorum virulent strain C79-13. In summary, in this study, a recombinant-attenuated S . Pullorum strain secreting NDV HN protein was constructed. The generation of the S . Pullorum C79-13Δ crp Δ asd (pYA-HN) strain provides a foundation for the development of an effective living-vector double vaccine against ND and PD.